EP3253797A4 - Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof - Google Patents

Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof Download PDF

Info

Publication number
EP3253797A4
EP3253797A4 EP16747125.9A EP16747125A EP3253797A4 EP 3253797 A4 EP3253797 A4 EP 3253797A4 EP 16747125 A EP16747125 A EP 16747125A EP 3253797 A4 EP3253797 A4 EP 3253797A4
Authority
EP
European Patent Office
Prior art keywords
chemokine
compositions
making
fusion polypeptides
immunoglobulin fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16747125.9A
Other languages
German (de)
French (fr)
Other versions
EP3253797A1 (en
Inventor
James W. Lillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jyant Technologies Inc
Original Assignee
Jyant Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/612,884 external-priority patent/US9249204B2/en
Application filed by Jyant Technologies Inc filed Critical Jyant Technologies Inc
Publication of EP3253797A1 publication Critical patent/EP3253797A1/en
Publication of EP3253797A4 publication Critical patent/EP3253797A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16747125.9A 2015-02-03 2016-02-02 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof Withdrawn EP3253797A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/612,884 US9249204B2 (en) 2011-06-01 2015-02-03 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
PCT/US2016/016191 WO2016126719A1 (en) 2015-02-03 2016-02-02 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Publications (2)

Publication Number Publication Date
EP3253797A1 EP3253797A1 (en) 2017-12-13
EP3253797A4 true EP3253797A4 (en) 2018-10-03

Family

ID=56564605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16747125.9A Withdrawn EP3253797A4 (en) 2015-02-03 2016-02-02 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Country Status (3)

Country Link
EP (1) EP3253797A4 (en)
CN (1) CN107207603A (en)
WO (1) WO2016126719A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139896A1 (en) * 2018-01-09 2019-07-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
AU2019271148B9 (en) * 2018-05-14 2025-05-29 Werewolf Therapeutics, Inc. Activatable interleukin-2 polypeptides and methods of use thereof
CA3100446A1 (en) * 2018-05-15 2019-11-21 Carsgen Therapeutics Co., Ltd. Genetically engineered cell and application thereof
KR20220044534A (en) * 2019-08-13 2022-04-08 엘피스 바이오파마슈티컬즈 Engineered Interleukin-2 Receptor Beta Agonists
CN111440244B (en) * 2020-04-09 2021-03-16 诺未科技（北京）有限公司 Metastatic cancer vaccine targeting VEGFR2
CN116209474A (en) * 2020-06-21 2023-06-02 技术研究及发展基金有限公司 Modified CXCL10 for immunotherapy of cancer diseases
US20230242606A1 (en) * 2020-06-21 2023-08-03 Technion Research & Development Foundation Limited Cxcl9 and variants thereof for immunotherapy of cancer diseases
TW202217002A (en) * 2020-07-13 2022-05-01 法商傳斯堅公司 Treatment of immune depression
CN113318120A (en) * 2021-06-07 2021-08-31 昆明医科大学第二附属医院 Application of miR4512 and CXCL2 in autoimmune diseases

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (en) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Therapeutic uses of chemokine variants
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
DK2229956T3 (en) * 2004-09-13 2013-07-29 Genzyme Corp Multimeric constructions
GB0605735D0 (en) * 2006-03-22 2006-05-03 Immunobiology Ltd Composition and method for mediating an immune response

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (en) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Therapeutic uses of chemokine variants
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130330337A1 (en) * 2011-06-01 2013-12-12 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016126719A1 *

Also Published As

Publication number Publication date
EP3253797A1 (en) 2017-12-13
WO2016126719A1 (en) 2016-08-11
CN107207603A (en) 2017-09-26

Similar Documents

Publication Publication Date Title
IL257030A (en) Multivalent and multispecific gitr-binding fusion proteins, compositions comprising same and uses thereof
EP3347472A4 (en) Compositions comprising cyp76ad1- clade polypeptides and uses thereof
EP3298033A4 (en) Compositions and methods for tcr reprogramming using fusion proteins
EP3104865A4 (en) Micro-organoids, and methods of making and using the same
EP3253797A4 (en) Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
IL275435B (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
EP3354653A4 (en) Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereof
EP3136879A4 (en) Concentrated protein compositions and methods of their making and use
EP3703676A4 (en) Composition and method for modifying polypeptides
EP3092248A4 (en) Fusion polypeptides and methods of use
EP3170808A4 (en) Polythiol composition and method for producing same
EP3237452A4 (en) Fusion proteins and methods thereof
EP3202775A4 (en) Conotoxin polypeptide kappa-cptx-bt104, and method for preparation thereof and application thereof
EP3323825A4 (en) Polypeptide compound and preparation method and use thereof
EP3315508A4 (en) Polypeptide compound and preparation method and use thereof
EP3270985A4 (en) Polypeptide compositions and methods of using the same
EP3269725A4 (en) Method for producing protein composition, and protein composition
EP3146968A4 (en) K2 composition, preparation method therefor, and application thereof
EP3202778A4 (en) Conotoxin polypeptide kappa-cptx-bt105, and method for preparation thereof and application thereof
EP3081581A4 (en) Diazoresin, photoresist composition and preparation method of photoresist composition
EP3392263A4 (en) Polypeptide compound, preparation method therefor and use thereof
EP3394174A4 (en) Composition, method of making composition, and article
EP3132790A4 (en) Exenatide-containing composition and preparation method therefor
EP3136864A4 (en) Compositions, methods of making a composition, and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170629

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180524BHEP

Ipc: A61K 39/395 20060101ALI20180524BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180904

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180829BHEP

Ipc: A61K 39/395 20060101ALI20180829BHEP

17Q First examination report despatched

Effective date: 20200203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200616